A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Clinical trial NCT06831370 · RECRUITING

Trial details

NCT number: NCT06831370
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hodgkin Lymphoma

Start date: 2024-08-28
Primary completion: 2028-03-31
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.